An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
M. A. Baxter (Lead / Corresponding author), L. C. Spender, D. Cairns, S. Walsh, R. Oparka, R.J. Porter, S. Bray, G. Skinner, S. King, J. Turbitt, D. Collinson, Z. H. Miedzybrodzka, G. Jellema, G. Logan, R. D. Kennedy, R. C. Turkington, M. H. McLean, D. Swinson, H. I. Grabsch, S. LordM. J. Seymour, P. S. Hall, R. D. Petty (Lead / Corresponding author)
Dive into the research topics of 'An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma'. Together they form a unique fingerprint.